Tags

Type your tag names separated by a space and hit enter

The use of systemic and topical fluoroquinolones.
Pediatrics. 2011 Oct; 128(4):e1034-45.Ped

Abstract

Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

21949152

Citation

Bradley, John S., et al. "The Use of Systemic and Topical Fluoroquinolones." Pediatrics, vol. 128, no. 4, 2011, pp. e1034-45.
Bradley JS, Jackson MA, Committee on Infectious Diseases, et al. The use of systemic and topical fluoroquinolones. Pediatrics. 2011;128(4):e1034-45.
Bradley, J. S., & Jackson, M. A. (2011). The use of systemic and topical fluoroquinolones. Pediatrics, 128(4), e1034-45. https://doi.org/10.1542/peds.2011-1496
Bradley JS, et al. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2011;128(4):e1034-45. PubMed PMID: 21949152.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The use of systemic and topical fluoroquinolones. AU - Bradley,John S, AU - Jackson,Mary Anne, AU - ,, AU - ,, Y1 - 2011/09/26/ PY - 2011/9/28/entrez PY - 2011/9/29/pubmed PY - 2011/12/13/medline SP - e1034 EP - 45 JF - Pediatrics JO - Pediatrics VL - 128 IS - 4 N2 - Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists. SN - 1098-4275 UR - https://www.unboundmedicine.com/medline/citation/21949152/full_citation L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=21949152 DB - PRIME DP - Unbound Medicine ER -